ResMed: GLP-1 Threats Are Overstated

Weight-loss drugs are a hot commodity. But not in low-income neighborhoods.

GLP-1 Discontinuation Less Common With Endocrinologists

Cigna VC’s bet on prescribing GLP-1s online; Plus: How the enterprise pitch is changing

Health News Roundup: Pfizer agrees to pay $93 million to settle Lipitor antitrust lawsuit; Denali-Sanofi’s ALS drug fails to meet mid-stage trial goal and more

Wegovy scripts for kids on the rise: Reuters

Pharmalittle: We’re reading about kids taking Wegovy, telehealth for abortion pills, and more

Morning Briefing

Exclusive: Wegovy fuels sharp rise in use of weight-loss drugs for US youth

Exclusive-US families begin to embrace weight-loss drugs for their children

What’s Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk’s Weight Loss Drug Wegovy

Super Bowl parade shooting, Indonesia’s election, Europe’s birth rate and young Wegovy users